Innovation Pharmaceuticals Inc (IPIX)

[frrol]

On a related note, cherry-picking in PR's is very common, and understandable: biotech and Pharmas like to toot the horn on what they believe is promising research results. Two things to keep in mind, though:

1. Investors need to know cherry-picking and acknowledge it for what it is.
2. The company's conclusion is the least important one. More important is potential partners' conclusions, and the most important is the FDA's. And naturally guess which two the market cares the most about.

New investors in biotech get misled by cherry-picking all the time. "The trial showed it works!!!" they shout. No. It showed it might work.